Literature DB >> 12967566

Polar expression of ErbB-2/HER2 in epithelia. Bimodal regulation by Lin-7.

Maya Shelly1, Yaron Mosesson, Ami Citri, Sara Lavi, Yaara Zwang, Naomi Melamed-Book, Benjamin Aroeti, Yosef Yarden.   

Abstract

ErbB-2/HER2 drives epithelial malignancies by forming heterodimers with growth factor receptors. The primordial invertebrate receptor is sorted to the basolateral epithelial surface by binding of the PDZ domain of Lin-7 to the receptor's tail. We show that all four human ErbBs are basolaterally expressed, even when the tail motif is absent. Mutagenesis of hLin-7 unveiled a second domain, KID, that binds to the kinase region of ErbBs. The PDZ interaction mediates stabilization of ErbB-2 at the basolateral surface. On the other hand, binding of KID is involved in initial delivery to the basolateral surface, and in its absence, unprocessed ErbB-2 molecules are diverted to the apical surface. Hence, distinct domains of Lin-7 regulate receptor delivery to and maintenance at the basolateral surface of epithelia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967566     DOI: 10.1016/j.devcel.2003.08.001

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  21 in total

1.  TIP-1 has PDZ scaffold antagonist activity.

Authors:  Christine Alewine; Olav Olsen; James B Wade; Paul A Welling
Journal:  Mol Biol Cell       Date:  2006-07-19       Impact factor: 4.138

2.  The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane.

Authors:  Camilla Haslekås; Kamilla Breen; Ketil W Pedersen; Lene E Johannessen; Espen Stang; Inger Helene Madshus
Journal:  Mol Biol Cell       Date:  2005-10-05       Impact factor: 4.138

3.  HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features.

Authors:  Rachel L Stewart; Justin E Caron; Evin H Gulbahce; Rachel E Factor; Katherine B Geiersbach; Erinn Downs-Kelly
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

4.  Deficiency of a membrane skeletal protein, 4.1G, results in myelin abnormalities in the peripheral nervous system.

Authors:  Yurika Saitoh; Nobuhiko Ohno; Junji Yamauchi; Takeharu Sakamoto; Nobuo Terada
Journal:  Histochem Cell Biol       Date:  2017-07-28       Impact factor: 4.304

Review 5.  Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Annu Rev Physiol       Date:  2013-11-08       Impact factor: 19.318

Review 6.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

7.  Erbin regulates NRG1 signaling and myelination.

Authors:  Yanmei Tao; Penggao Dai; Yu Liu; Sylvie Marchetto; Wen-Cheng Xiong; Jean-Paul Borg; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-20       Impact factor: 11.205

Review 8.  Endocytosis and intracellular trafficking of ErbBs.

Authors:  Alexander Sorkin; Lai Kuan Goh
Journal:  Exp Cell Res       Date:  2008-08-28       Impact factor: 3.905

9.  LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.

Authors:  Gal Gur; Chanan Rubin; Menachem Katz; Ido Amit; Ami Citri; Jonas Nilsson; Ninette Amariglio; Roger Henriksson; Gideon Rechavi; Håkan Hedman; Ron Wides; Yosef Yarden
Journal:  EMBO J       Date:  2004-07-29       Impact factor: 11.598

10.  The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface.

Authors:  Cheri S Lazar; Catherine M Cresson; Douglas A Lauffenburger; Gordon N Gill
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.